| 3.46 Data as of 2:53pm ET |  +0.155 / +4.70%Today’s Change | 1.58 Today|||52-Week Range 3.89 | +19.97% Year-to-Date |
| Previous close | 3.30 |
| Today’s open | 3.34 |
| Day’s range | 3.33 - 3.50 |
| Volume | 661,203 |
| Average volume (3 months) | 459,621 |
| Market cap | $191.2M |
| Dividend yield | -- |
| Earnings growth (last year) | +28.72% |
| Earnings growth (this year) | +13.43% |
| Earnings growth (next 5 years) | +20.00% |
| Revenue growth (last year) | +100.47% |
| P/E ratio | NM |
| Price/Sales | 27.90 |
| Price/Book | 4.38 |
| Today’s change | Today’s % change | |
|---|---|---|
| SIGASIGA Technologies In... | -0.11 | -3.06% |
| VSTMVerastem Inc | -0.21 | -2.26% |
| CGENCompugen Ltd | -0.02 | -0.36% |
| PSTIPluristem Therapeuti... | +0.06 | +2.00% |
| Next reporting date | August 13, 2013 |
| EPS forecast (this quarter) | -$0.15 |
| Annual revenue (last year) | $5.1M |
| Annual profit (last year) | -$32.9M |
| Net profit margin | -647.34% |
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director Michael K. McGarrity |
Chief Financial Officer, Secretary & Treasurer John Roger Moody, Jr., MBA |
Corporate headquarters Northbrook, Illinois |
.
